Smart testing for smart drugs
04 January 2010Can better decisions be made about which anticancer drugs to progress to clinical trials?
Research
Can better decisions be made about which anticancer drugs to progress to clinical trials?
Professor Sir Bruce Ponder describes the vision of a Cambridge-wide initiative to link world-class cancer research to improved patient care.
Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.
Cambridge scientists are asking what role stem cells play in how cancer develops, spreads and relapses.
Rolls-Royce and the Engineering and Physical Sciences Research Council will work jointly with the Universities of Cambridge, Birmingham and Swansea in a new £50 million...
PneumaCare, the first company to receive funding from the University of Cambridge Discovery Fund, is a new model for utilising academic expertise.
A new generation of cancer therapeutics is on the horizon thanks to fresh light being shed on how genes are switched on and off.
Excavation of the deepest archaeological trench in North Africa half a century after it was first dug is offering a glimpse of up to 200,000...
Dr Zoltán Tiba’s research on why famines happen is posing questions about the root causes and possible long-term interventions.
The book publishing industry has gone through more change during the past few decades than in any comparable period in its 500-year history. Professor John...